Treatment of disorders secondary to organic impairments

a technology for organic impairment and disorders, applied in the field of treating disorders secondary to organic impairment, can solve the problems of major psychiatric disturbance, abnormal limbic or neuronal sensitization, hyperactivity, and hypersensitivity, and achieve the effect of reducing attention, hyperactivity, and hyperactivity, and preventing the development of ptsd
US20030207943A1Inactive Publication Date: 2003-11-06SNOWDEN PHARMA
0 Cites 2 Cited by

Patent Information

Authority / Receiving Office
US · United States
Patent Type
Applications(United States)
Current Assignee / Owner
SNOWDEN PHARMA
Publication Date
2003-11-06
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

A method for treatment of neuropsychiatric symptoms or disorders emanating from primary brain or systemic impairments includes administration of an effective dose of a dopamine, serotonin, and norepinephrine reuptake inhibitor to a human in need of such treatment. The preferred reuptake inhibitor is sibutramine.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a continuation-in-part application of U.S. application Ser. No. 09 / 204,124 filed Dec. 2, 1998.

[0002] The present invention relates to the pharmacological treatment of various secondary neurological, behavioral and cognitive symptoms or disorders emanating out of brain or systemic impairments, i.e, primary impairments.

[0003] The secondary symptoms and disorders include as non-limiting examples, tic and behavioral disorders including Tourette's syndrome and severe non-Tourette's motor or vocal tics; Posttraumatic Stress Disorder (PTSD); a typical attention deficit disorder with or without hyperactivity; frontal lobe defects of executive function; oscillopsia; self-mutilation; violence or rage such as in intermittent explosive disorder; asocial behavior; sexual disorders (including gender choice difficulties or hyposexuality); psychological (psychosis, violence, and confusion) and motor symptoms of Huntington's Disease (Huntington's Chorea); fatigue, exhausti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More